Evidence map›Paper›PMID 31504264›Full record

ArticleCardiovascular research2020

Human iPSC modelling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes.

Patrizia Benzoni, Giulia Campostrini, Sara Landi, Valeria Bertini, Eleonora Marchina, Maria Iascone, Gustav Ahlberg, Morten Salling Olesen, Elisabetta Crescini, Cristina Mora and 19 more

Open access · bronzeAbstract read
In one paragraph

Article in Cardiovascular research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Early Atrial Remodeling Drives Arrhythmia in Fabry Disease.Circulation. Arrhythmia and electrophysiology · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. Stem cell models of inherited arrhythmias.Nature cardiovascular research · 2024
    Review
  14. Article
  15. Article
  16. Biophysical properties of NaScientific reports · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors at 10 institutions in 4 countries.

Patrizia BenzoniDepartment of Biosciences, Università degli Studi di Milano, via Celoria 26, 20133 Milan, Italy.
Giulia CampostriniDepartment of Biosciences, Università degli Studi di Milano, via Celoria 26, 20133 Milan, Italy.
Sara LandiDepartment of Biosciences, Università degli Studi di Milano, via Celoria 26, 20133 Milan, Italy.
Valeria BertiniDepartment of Molecular and Translational Medicine, cFRU lab, Università degli Studi di Brescia, viale Europa 11, 25123 Brescia, Italy.
Eleonora MarchinaDepartment of Molecular and Translational Medicine, cFRU lab, Università degli Studi di Brescia, viale Europa 11, 25123 Brescia, Italy.
Maria IasconeUSSD Laboratorio di Genetica Medica, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Piazza OMS, 1, 24127 Bergamo, Italy.
Gustav AhlbergThe Heart Centre, Rigshospitalet, Laboratory for Molecular Cardiology, Blegdamsvej 9, 2100 Copenhagen, Denmark.
Morten Salling OlesenThe Heart Centre, Rigshospitalet, Laboratory for Molecular Cardiology, Blegdamsvej 9, 2100 Copenhagen, Denmark.
Elisabetta CresciniDepartment of Molecular and Translational Medicine, cFRU lab, Università degli Studi di Brescia, viale Europa 11, 25123 Brescia, Italy.
Cristina MoraDepartment of Molecular and Translational Medicine, cFRU lab, Università degli Studi di Brescia, viale Europa 11, 25123 Brescia, Italy.
Gianluigi BisleriDepartment of Surgery, Division of Cardiac Surgery, Queen's University, 99 University Avenue, Kingston, Ontario K7L 3N6, Canada.
Claudio MunerettoClinical Department of Cardiovascular Surgery, University of Brescia, viale Europa 11, 25123 Brescia, Italy.
Roberto RoncaDepartment of Molecular and Translational Medicine, cFRU lab, Università degli Studi di Brescia, viale Europa 11, 25123 Brescia, Italy.
Marco PrestaDepartment of Molecular and Translational Medicine, cFRU lab, Università degli Studi di Brescia, viale Europa 11, 25123 Brescia, Italy.
Pier Luigi PolianiDepartment of Molecular and Translational Medicine, cFRU lab, Università degli Studi di Brescia, viale Europa 11, 25123 Brescia, Italy.
Giovanna PiovaniDepartment of Molecular and Translational Medicine, cFRU lab, Università degli Studi di Brescia, viale Europa 11, 25123 Brescia, Italy.
Rosanna VerardiDepartment of Trasfusion Medicine, Laboratory for Stem Cells Manipulation and Cryopreservation, ASST Spedali Civili, viale Europa 11, 25123 Brescia, Italy.
Elisa Di PasqualeDepartment of Cardiovascular Medicine, Humanitas Clinical and Research Center, Via Rita Levi Montalcini, 4, 20090 Pieve Emanuele, Milan, Italy.
Antonella ConsiglioDepartment of Molecular and Translational Medicine, cFRU lab, Università degli Studi di Brescia, viale Europa 11, 25123 Brescia, Italy.
Angel RayaCenter of Regenerative Medicine in Barcelona (CMRB), Hospital Duran i Reynals, Hospitalet de Llobregat, 08908 Barcelona, Spain.
Eleonora TorreDepartment of Biotechnology and Biosciences, Università degli Studi di Milano-Bicocca, iazza dell'Ateneo Nuovo 1, 20126 Milan, Italy.
Alessandra Maria LodriniDepartment of Biotechnology and Biosciences, Università degli Studi di Milano-Bicocca, iazza dell'Ateneo Nuovo 1, 20126 Milan, Italy.
Raffaella MilanesiDepartment of Biosciences, Università degli Studi di Milano, via Celoria 26, 20133 Milan, Italy.
Marcella RocchettiDepartment of Biotechnology and Biosciences, Università degli Studi di Milano-Bicocca, iazza dell'Ateneo Nuovo 1, 20126 Milan, Italy.
Mirko BaruscottiDepartment of Biosciences, Università degli Studi di Milano, via Celoria 26, 20133 Milan, Italy.
Dario DiFrancescoDepartment of Biosciences, Università degli Studi di Milano, via Celoria 26, 20133 Milan, Italy.
Maurizio MemoDepartment of Molecular and Translational Medicine, cFRU lab, Università degli Studi di Brescia, viale Europa 11, 25123 Brescia, Italy.
Andrea BarbutiDepartment of Biosciences, Università degli Studi di Milano, via Celoria 26, 20133 Milan, Italy.
Patrizia Dell'EraDepartment of Molecular and Translational Medicine, cFRU lab, Università degli Studi di Brescia, viale Europa 11, 25123 Brescia, Italy.
University of Brescia · ITUniversity of Milan · ITUniversity of Milano-Bicocca · ITRigshospitalet · DKAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITBellvitge University Hospital · ESHumanitas University · ITInstitució Catalana de Recerca i Estudis Avançats · ESOspedale Papa Giovanni XXIII · ITQueen's University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsAtrial fibrillation (AF) is the most common type of cardiac arrhythmias, whose incidence is likely to increase with the aging of the population. It is considered a progressive condition, frequently observed as a complication of other cardiovascular disorders. However, recent genetic studies revealed the presence of several mutations and variants linked to AF, findings that define AF as a multifactorial disease. Due to the complex genetics and paucity of models, molecular mechanisms underlying the initiation of AF are still poorly understood. Here we investigate the pathophysiological mechanisms of a familial form of AF, with particular attention to the identification of putative triggering cellular mechanisms, using patient's derived cardiomyocytes (CMs) differentiated from induced pluripotent stem cells (iPSCs). METHODS AND

resultsHere we report the clinical case of three siblings with untreatable persistent AF whose whole-exome sequence analysis revealed several mutated genes. To understand the pathophysiology of this multifactorial form of AF we generated three iPSC clones from two of these patients and differentiated these cells towards the cardiac lineage. Electrophysiological characterization of patient-derived CMs (AF-CMs) revealed that they have higher beating rates compared to control (CTRL)-CMs. The analysis showed an increased contribution of the If and ICaL currents. No differences were observed in the repolarizing current IKr and in the sarcoplasmic reticulum calcium handling. Paced AF-CMs presented significantly prolonged action potentials and, under stressful conditions, generated both delayed after-depolarizations of bigger amplitude and more ectopic beats than CTRL cells.

conclusionsOur results demonstrate that the common genetic background of the patients induces functional alterations of If and ICaL currents leading to a cardiac substrate more prone to develop arrhythmias under demanding conditions. To our knowledge this is the first report that, using patient-derived CMs differentiated from iPSC, suggests a plausible cellular mechanism underlying this complex familial form of AF.

Indexed as

MutationAction PotentialsAnti-Arrhythmia AgentsAtrial FibrillationCalcium Channels, L-TypeCase-Control StudiesCell DifferentiationCells, CulturedDrug ResistanceExome SequencingGenetic Predisposition to DiseaseHeart RateHumansHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsInduced Pluripotent Stem CellsMiddle AgedAnti-Arrhythmia AgentsCalcium Channels, L-TypeHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsArrhythmiasAtrial fibrillationIon channelsiPSC-derived cardiomyocytesPrecision medicine

Identifiers

PMID31504264
PMCPMC7177512
OpenAlexW2970267181

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.